3D Bioprinted Human Tissue Market Size to Hit USD 5.67 Billion by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on 3D Bioprinted Human Tissue Market

5.1. COVID-19 Landscape: Smart Water Metering Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global 3D Bioprinted Human Tissue Market, By Tissue Type

8.1. 3D Bioprinted Human Tissue Market Revenue and Volume Forecast, by Tissue Type

8.1.1. Skin Tissue

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Liver Tissue

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Cardiac Tissue

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Bone & Cartilage Tissue

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Other Tissues (kidney, neural, lung)

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global 3D Bioprinted Human Tissue Market, By Technology

9.1. 3D Bioprinted Human Tissue Market Revenue and Volume Forecast, by Technology

9.1.1. Extrusion-based Bioprinting

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Inkjet-based Bioprinting

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Laser-assisted Bioprinting

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Other Bioprinting Technologies

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global 3D Bioprinted Human Tissue Market, By Cell Source

10.1. 3D Bioprinted Human Tissue Market Revenue and Volume Forecast, by Cell Source

10.1.1. Primary Human Cells

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Stem Cells (ESCs, iPSCs)

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Immortalized Cell Lines

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global 3D Bioprinted Human Tissue Market, By Application

11.1. 3D Bioprinted Human Tissue Market Revenue and Volume Forecast, by Application

11.1.1. Drug Discovery & Toxicity Testing

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Disease Modeling

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Regenerative Medicine Research

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Other Applications

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global 3D Bioprinted Human Tissue Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Tissue Type

12.1.2. Market Revenue and Volume Forecast, by Technology

12.1.3. Market Revenue and Volume Forecast, by Cell Source

12.1.4. Market Revenue and Volume Forecast, by Application

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Tissue Type

12.1.5.2. Market Revenue and Volume Forecast, by Technology

12.1.5.3. Market Revenue and Volume Forecast, by Cell Source

12.1.5.4. Market Revenue and Volume Forecast, by Application

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Tissue Type

12.1.6.2. Market Revenue and Volume Forecast, by Technology

12.1.6.3. Market Revenue and Volume Forecast, by Cell Source

12.1.6.4. Market Revenue and Volume Forecast, by Application

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Tissue Type

12.2.2. Market Revenue and Volume Forecast, by Technology

12.2.3. Market Revenue and Volume Forecast, by Cell Source

12.2.4. Market Revenue and Volume Forecast, by Application

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Tissue Type

12.2.5.2. Market Revenue and Volume Forecast, by Technology

12.2.5.3. Market Revenue and Volume Forecast, by Cell Source

12.2.5.4. Market Revenue and Volume Forecast, by Application

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Tissue Type

12.2.6.2. Market Revenue and Volume Forecast, by Technology

12.2.6.3. Market Revenue and Volume Forecast, by Cell Source

12.2.6.4. Market Revenue and Volume Forecast, by Application

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Tissue Type

12.2.7.2. Market Revenue and Volume Forecast, by Technology

12.2.7.3. Market Revenue and Volume Forecast, by Cell Source

12.2.7.4. Market Revenue and Volume Forecast, by Application

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Tissue Type

12.2.8.2. Market Revenue and Volume Forecast, by Technology

12.2.8.3. Market Revenue and Volume Forecast, by Cell Source

12.2.8.4. Market Revenue and Volume Forecast, by Application

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Tissue Type

12.3.2. Market Revenue and Volume Forecast, by Technology

12.3.3. Market Revenue and Volume Forecast, by Cell Source

12.3.4. Market Revenue and Volume Forecast, by Application

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Tissue Type

12.3.5.2. Market Revenue and Volume Forecast, by Technology

12.3.5.3. Market Revenue and Volume Forecast, by Cell Source

12.3.5.4. Market Revenue and Volume Forecast, by Application

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Tissue Type

12.3.6.2. Market Revenue and Volume Forecast, by Technology

12.3.6.3. Market Revenue and Volume Forecast, by Cell Source

12.3.6.4. Market Revenue and Volume Forecast, by Application

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Tissue Type

12.3.7.2. Market Revenue and Volume Forecast, by Technology

12.3.7.3. Market Revenue and Volume Forecast, by Cell Source

12.3.7.4. Market Revenue and Volume Forecast, by Application

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Tissue Type

12.3.8.2. Market Revenue and Volume Forecast, by Technology

12.3.8.3. Market Revenue and Volume Forecast, by Cell Source

12.3.8.4. Market Revenue and Volume Forecast, by Application

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Tissue Type

12.4.2. Market Revenue and Volume Forecast, by Technology

12.4.3. Market Revenue and Volume Forecast, by Cell Source

12.4.4. Market Revenue and Volume Forecast, by Application

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Tissue Type

12.4.5.2. Market Revenue and Volume Forecast, by Technology

12.4.5.3. Market Revenue and Volume Forecast, by Cell Source

12.4.5.4. Market Revenue and Volume Forecast, by Application

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Tissue Type

12.4.6.2. Market Revenue and Volume Forecast, by Technology

12.4.6.3. Market Revenue and Volume Forecast, by Cell Source

12.4.6.4. Market Revenue and Volume Forecast, by Application

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Tissue Type

12.4.7.2. Market Revenue and Volume Forecast, by Technology

12.4.7.3. Market Revenue and Volume Forecast, by Cell Source

12.4.7.4. Market Revenue and Volume Forecast, by Application

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Tissue Type

12.4.8.2. Market Revenue and Volume Forecast, by Technology

12.4.8.3. Market Revenue and Volume Forecast, by Cell Source

12.4.8.4. Market Revenue and Volume Forecast, by Application

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Tissue Type

12.5.2. Market Revenue and Volume Forecast, by Technology

12.5.3. Market Revenue and Volume Forecast, by Cell Source

12.5.4. Market Revenue and Volume Forecast, by Application

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Tissue Type

12.5.5.2. Market Revenue and Volume Forecast, by Technology

12.5.5.3. Market Revenue and Volume Forecast, by Cell Source

12.5.5.4. Market Revenue and Volume Forecast, by Application

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Tissue Type

12.5.6.2. Market Revenue and Volume Forecast, by Technology

12.5.6.3. Market Revenue and Volume Forecast, by Cell Source

12.5.6.4. Market Revenue and Volume Forecast, by Application

Chapter 13. Company Profiles

13.1. Organovo

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Stratasys

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Poietis

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Aspect Biosystems

13.4.1. Company Overview

13.4.2. RegenHU

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Prellis Biologics

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Cyfuse Biomedical

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. FabRx

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. 3D Bioprinting Solutions

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. CELLuink

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Inventia Life Science

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The global 3D bioprinted human tissue market size is expected to grow from USD 2.60 billion in 2025 to USD 5.67 billion by 2035.

Answer : The 3D bioprinted human tissue market is anticipated to grow at a CAGR of 8.13% between 2026 and 2035.

Answer : The 3D bioprinted human tissue market is driven by the rising shortage of donor organs, increasing prevalence of chronic diseases, and the growing need for alternatives to animal testing in drug discovery and research. Additionally, rapid advancements in bioprinting technologies, stem cell research, AI integration, and the rising focus on personalized medicine are accelerating market growth.

Answer : North America region will lead the global 3D bioprinted human tissue market during the forecast period 2026 to 2035.